BETA

Activities of Olle SCHMIDT related to 2012/0366(COD)

Plenary speeches (1)

Manufacture, presentation and sale of tobacco and related products (debate)
2016/11/22
Dossiers: 2012/0366(COD)

Shadow opinions (1)

OPINION on the proposal for a directive of the European Parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products
2016/11/22
Committee: IMCO
Dossiers: 2012/0366(COD)
Documents: PDF(437 KB) DOC(706 KB)

Amendments (10)

Amendment 90 #
Proposal for a directive
Recital 26
(26) Considerable volumes of illicit products, which do not comply with the requirements laid down in Directive 2001/37/EC, are placed on the market and indications are that these volumes might increase. Such products undermine the free circulation of compliant products and the protection provided for by tobacco control legislations. In addition, the FCTC obliges the Union to fight against illicit products, as part of a comprehensive tobacco control policy. Provision should thus be made for unit packets of tobacco products to be marked in a unique and secure way and their movements to be recorded so that these products can be tracked and traced in the Union and their compliance with this Directive can be monitored and better enforced. In addition, provision should be made for the introduction of security features that will facilitate the verification of whether or not products are authentic. Coherent implementation of customs legislation will strengthen customs authorities in their fight against illicit trade, in particular through technical capacity building.
2013/05/08
Committee: IMCO
Amendment 98 #
Proposal for a directive
Recital 34
(34) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use provides a legal framework to assess the quality, safety and efficacy of medicinal products including nicotine containing products. A significant number of nicotine-containing products were already authorised under this regulatory regime. The authorisation takes into account the nicotine content of the product in question. Subjecting all nicotine- containing products, whose nicotine content equals or exceeds the content of a nicotine containing product previously authorised under Directive 2001/83/EC, intended for medical purposes for humans to the same legal framework clarifies the legal situation, levels out differences between national legislations, ensures equal treatment of all nicotine containing products usable for smoking cessation purposes and creates incentives for research and innovation in smoking cessation. This should be without prejudice to the application of Directive 2001/83/EC to other products covered by this Directive if the conditions set by Directive 2001/83/EC are fulfilled.
2013/05/08
Committee: IMCO
Amendment 179 #
Proposal for a directive
Article 6 – paragraph 1 – subparagraph 1
Member States shall prohibit the placing on the market of tobacco products with a characterising flavour, without prejudice to Article 151 of the Act of Accession of Austria, Finland and Sweden.
2013/05/08
Committee: IMCO
Amendment 206 #
Proposal for a directive
Article 7 – paragraph 1
1. Each unit packet of tobacco products and any outside packaging shall carry health warnings in the official language or languages of the Member State where the product is placed on the market, without prejudice to Article 151 of the Act of Accession of Austria, Finland and Sweden.
2013/05/08
Committee: IMCO
Amendment 276 #
Proposal for a directive
Article 10 – paragraph 1 – subparagraph 2
The general warning shall be printed or affixed by means of irremovable stickers on the most visible surface of the unit packet and any outside packaging. The text warnings listed in Annex I shall be rotated in such a way as to guarantee their regular appearance. These warnings shall be printedappear on the other most visible surface of the unit packet and any outside packaging.
2013/05/13
Committee: IMCO
Amendment 284 #
Proposal for a directive
Article 10 – paragraph 4 – point a
(a) printedappear in black Helvetica bold type on a white background. In order to accommodate language requirements, Member States may determine the point size of the font, provided that the font size specified in their legislation is such as to occupy the greatest possible proportion of the area set aside for the text required;
2013/05/13
Committee: IMCO
Amendment 285 #
Proposal for a directive
Article 10 – paragraph 4 – point b
(b) centred in the area in which they are required to be printedappear, parallel to the top edge of the unit packet and any outside packaging;
2013/05/13
Committee: IMCO
Amendment 342 #
Proposal for a directive
Article 14 – paragraph 1
1. Member States shall ensure that all unit packets of tobacco products shall be marked with a unique identifier used together with a digital tax stamp in invisible ink. In order to ensure their integrity, unique identifiers shall be irremovably printed/affixed, indelible and in no way hidden or interrupted in any form, including through tax stamps and price marks, or by the opening of the packet. In relation to products manufactured outside the Union the obligations laid down in this Article apply only to those destined to or placed on the Union market.
2013/05/13
Committee: IMCO
Amendment 422 #
Proposal for a directive
Article 18 – paragraph 1 – introductory part
1. The following nNicotine-containing products intended for medical purposes for humans, may only be placed on the market if they were authorised pursuant to Directive 2001/83/EC:.
2013/05/13
Committee: IMCO
Amendment 428 #
Proposal for a directive
Article 18 – paragraph 1 e (new)
1e. For nicotine-containing products where paragraph 1 does not apply, the products may be placed on the market if they comply with this Directive.
2013/05/13
Committee: IMCO